Experimental weight loss drug retatrutide shows dramatic weight loss in clinical trial Amid the growing demand for GLP-1 medications for weight loss, a new experimental drug, retatrutide, stands out, according to new clinical trial results released on Thursday
However, the relevance of these findings and hence of the role of lysosomal cathepsin D in in vivo APAP-mediated acute liver failure is uncertain given the minor role of CYP3A4 in APAP metabolism (see above)
Moawad AR, Tan SL, Xu B, Chen HY, Taketo T
TB-500 operates systemically as a **cytoskeleton remodeler**: its primary function is G-actin monomer sequestration (active N-terminal Ac-Ser-Asp-Lys-Pro), its cleaved AcSDKP sequence is an **autonomous angiogenic factor**, it upregulates laminin-5 and matrix metalloproteinases (MMPs), and mobilizes mesenchymal progenitor cells
The maker of Ozempic, Wegovy and Rybelsus is down nearly 28% over the past year, with a market cap of around $169 billion